These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 222901)

  • 41. Clinical and endometrial effects of oestradiol and progesterone in post-menopausal women.
    Darj E; Nilsson S; Axelsson O; Hellberg D
    Maturitas; 1991 Jun; 13(2):109-15. PubMed ID: 1921733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative endocrinological and clinical effects of percutaneous estradiol and oral conjugated estrogens as replacement therapy in menopausal women.
    Dupont A; Dupont P; Cusan L; Tremblay M; Rioux J; Cloutier D; Mailloux J; De Lignières B; Gutkowska J; Boucher H
    Maturitas; 1991 Oct; 13(4):297-311. PubMed ID: 1663571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sonographic changes in the endometrium of climacteric women during hormonal treatment.
    Schurz B; Metka M; Heytmanek G; Wimmer-Greinecker G; Reinold E
    Maturitas; 1988 Mar; 9(4):367-74. PubMed ID: 2837621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of 'natural' oestrogen replacement therapy on menopausal symptoms.
    Coope J
    Postgrad Med J; 1976; 52 Suppl 6():27. PubMed ID: 185604
    [No Abstract]   [Full Text] [Related]  

  • 45. Dose dependent effects of oral progesterone on the oestrogenised postmenopausal endometrium.
    Lane G; Siddle NC; Ryder TA; Pryse-Davies J; King RJ; Whitehead MI
    Br Med J (Clin Res Ed); 1983 Oct; 287(6401):1241-5. PubMed ID: 6315123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Minimal dose combined hormonal replacement therapy for menopausal women.
    Wren BG
    Med J Aust; 1981 Apr; 1(7):353-6. PubMed ID: 7242418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new combination of conjugated equine oestrogens and medroxyprogesterone for treatment of climacteric complaints.
    Cullberg G; Knutsson F; Mattsson LA
    Maturitas; 1984 Jul; 6(1):55-63. PubMed ID: 6088950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of progesterone injection on progesterone receptor levels and distribution in untreated and short-term Premarin-primed pre-menopausal and post-menopausal endometrium.
    Gorodeski IG; Geier A; Lunenfeld B; Sigal A; Beery R; Serr D; Bahary CM
    Maturitas; 1986 Dec; 8(4):353-8. PubMed ID: 3033446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
    Varma TR
    Acta Obstet Gynecol Scand; 1985; 64(1):41-6. PubMed ID: 2983513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Difference between effects of conjugated estrogen on neurotics and non-neurotics of climacteric women complaining of menopausal symptoms and its clinical application for their screening.
    Abe T; Furuhashi N; Ohashi I; Suzuki M
    Tohoku J Exp Med; 1976 Jun; 119(2):197-200. PubMed ID: 181869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Micronized progesterone regulation of the endometrial glandular cycling pool.
    Moyer DL; Felix JC; Kurman RJ; Cuffie CA
    Int J Gynecol Pathol; 2001 Oct; 20(4):374-9. PubMed ID: 11603222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of progesterone administered by nasal spray on the human postmenopausal endometrium.
    Cicinelli E; Petruzzi D; Scorcia P; Resta L
    Maturitas; 1993 Dec; 18(1):65-72. PubMed ID: 8107618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Combined hormonal therapy of climacteric syndrome using tristeroid preparation "Trophobolene"].
    Teter J; Potocki J; Kloś J
    Ginekol Pol; 1969 Mar; 40(3):279-84. PubMed ID: 4306535
    [No Abstract]   [Full Text] [Related]  

  • 54. Postmenopausal hormone replacement therapy with estrogen periodically supplemented with antiestrogen.
    Kauppila A; Jänne O; Kivinen S; Kokko E; Lantto T; Tuimala R; Vihko R
    Am J Obstet Gynecol; 1981 Aug; 140(7):787-92. PubMed ID: 6266254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tamoxifen and natural progesterone as supplements to low-dose postmenopausal estrogen therapy.
    Kauppila A; Kivinen S; Stenbäck F; Vihko R; Vuopala S
    Gynecol Obstet Invest; 1988; 25(1):58-65. PubMed ID: 3277903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Results of a 5 years prospective study of estriol succinate treatment in patients with climacteric complaints.
    Lauritzen C
    Horm Metab Res; 1987 Nov; 19(11):579-84. PubMed ID: 3428874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endometrial, physical and psychological effects of postmenopausal oestrogen therapy with added dydrogesterone.
    Siddle NC; Fraser D; Whitehead MI; Jesinger DK; Endacott J; Prescott P; Pryse-Davies J
    Br J Obstet Gynaecol; 1990 Dec; 97(12):1101-7. PubMed ID: 2177648
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Secretory endometrium associated with breakthrough bleeding in estrogen-treated postmenopausal women.
    Honoré LH
    Eur J Obstet Gynecol Reprod Biol; 1977; 7(3):141-5. PubMed ID: 233742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Micronized 17 beta-estradiol for oral estrogen therapy in menopausal women.
    Callantine MR; Martin PL; Bolding OT; Warner PO; Greaney MO
    Obstet Gynecol; 1975 Jul; 46(1):37-41. PubMed ID: 1153135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psychological changes effected by estrogen-progestogen and clonidine treatment in climacteric women.
    Gerdes LC; Sonnendecker EW; Polakow ES
    Am J Obstet Gynecol; 1982 Jan; 142(1):98-104. PubMed ID: 6275706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.